385.9K XNYS Volume
XNYS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Lisa Michelle Kallebo | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 41,900 | 77,897 | - | 1.6 | 67,459 | Common Shares |
| Mohamed Zaki | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 230,000 | 462,888 | - | 1.6 | 370,300 | Common Shares |
| Ameet Mallik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 650,000 | 1,579,005 | - | 1.6 | 1,046,500 | Common Shares |
| Jose Carmona | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 240,000 | 541,892 | - | 1.6 | 386,400 | Common Shares |
| Peter J. Graham | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 220,000 | 408,542 | - | 1.6 | 354,200 | Common Shares |
| Lisa Michelle Kallebo | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 6,503 | 35,997 | - | 3.1 | 20,354 | Common Shares |
| Mohamed Zaki | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 37,112 | 232,888 | - | 3.1 | 116,161 | Common Shares |
| Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 238,343 | 929,005 | - | 3.1 | 746,014 | Common Shares |
| Jose Carmona | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 48,108 | 301,892 | - | 3.1 | 150,578 | Common Shares |
| Peter J. Graham | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 41,458 | 188,542 | - | 3.1 | 129,764 | Common Shares |
| Viviane Monges | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 1,437 | 106,627 | - | 2.9 | 4,153 | Common Shares |
| Thomas Pfisterer | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 1,437 | 213,900 | - | 2.9 | 4,153 | Common Shares |
| Peter Hug | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 1,193 | 182,644 | - | 2.9 | 3,448 | Common Shares |
| Robert W. Azelby | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 53,005 | - | 2.9 | 20,216 | Common Shares |
| Jean-Pierre Bizzari | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 79,502 | - | 2.9 | 20,216 | Common Shares |
| Victor Sandor | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 80,886 | - | 2.9 | 20,216 | Common Shares |
| Ron Squarer | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 80,663 | - | 2.9 | 20,216 | Common Shares |
| Thomas Pfisterer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 215,337 | - | 0 | Common Shares | |
| Peter Hug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 183,837 | - | 0 | Common Shares | |
| Viviane Monges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 108,064 | - | 0 | Common Shares | |
| Robert W. Azelby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 60,000 | - | 0 | Common Shares | |
| Jean-Pierre Bizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 86,497 | - | 0 | Common Shares | |
| Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 87,881 | - | 0 | Common Shares | |
| Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 87,658 | - | 0 | Common Shares | |
| Ameet Mallik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 07 May 2024 | 29,731 | 1,167,348 | - | 4.5 | 133,195 | Common Shares |